Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) reported Q3 EPS of ($0.19), $0.08 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $8.3 million versus the consensus estimate of $8.3 million.

For earnings history and earnings-related data on Vanda Pharmaceuticals, Inc. (VNDA) click here.

Earnings